---

---

symbols : INCY    crawled time : 21:00   

save search

---

Incyte to Report First Quarter Financial Results - April 11, 2024
Published: 2024-04-11 (Crawled : 21:00) - biospace.com/
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -5.93% | O: 0.62% H: 1.17% C: -0.76%
first report financial results

---

Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| -0.72% | O: -0.6% H: 0.45% C: 0.08%
MRUS | $41.97 2.82% 2.72% 740K |

Health Technology

| -13.82% | O: 2.3% H: 0.58% C: -2.69%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -13.74% | O: 0.38% H: 0.0% C: -3.07%
business year update financial results

---

The Changing Market Landscape of Benign Soft Tissue Sarcomas: Tenosynovial Giant Cell Tumors (TGCTs), Perivascular Epithelioid Cell Neoplasm (PEComa), Neurofibroma, and Vestibular Schwannoma | Key Insights and Findings by DelveInsight
Published: 2023-10-23 (Crawled : 21:00) - prnewswire.com
GNLX | $3.45 -0.86% -0.87% 140K |

| -82.23% | O: 0.41% H: 1.44% C: 0.82%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -3.02% | O: -1.2% H: 0.0% C: 0.0%
SWTX | $43.38 -1.41% -1.45% 500K |

Health Technology

| 100.0% | O: 1.34% H: 4.5% C: 3.37%
RVMD | $35.59 -1.85% -1.97% 1.3M |

Health Technology

| 93.9% | O: -0.14% H: 15.49% C: 14.68%
IOVA 4 | $11.71 -1.27% -1.45% 2.9M |

Health Technology

| 239.42% | O: 1.74% H: 12.82% C: 12.25%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -6.1% | O: 0.51% H: 0.94% C: -0.78%
tumors cell market

---

Large Granular Lymphocyte Leukemia Market is Projected to Grow During the Study Period (2019-2032), Assesses DelveInsight | Key Companies - Bristol Myers Squibb, Innate Pharma, Kymera Therapeutics, EUSA Pharma, Abcuro, Dren Bio, Novotech
Published: 2023-10-16 (Crawled : 21:00) - prnewswire.com
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -6.05% | O: -0.61% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -13.15% | O: -0.4% H: 0.0% C: 0.0%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -10.22% | O: -0.21% H: 0.7% C: -0.56%
companies leukemia study market

---

Leptomeningeal Metastases Treatment Market to Register Immense Growth by 2032, Predicts DelveInsight
Published: 2023-10-11 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -14.67% | O: -0.97% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -13.48% | O: 0.14% H: 0.0% C: 0.0%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -9.16% | O: -0.05% H: 0.0% C: -0.63%
treatment growth market

---

Knight Therapeutics Announces Regulatory Submission of Pemigatinib in Brazil
Published: 2023-10-10 (Crawled : 21:00) - globenewswire.com
XNCR | $19.02 3.54% 3.57% 760K |

Health Technology

| -1.76% | O: 0.05% H: 3.15% C: -2.53%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -9.61% | O: 0.45% H: 0.52% C: -0.94%
brazil therapeutics submission

---

The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand Disease | Key Analysis by DelveInsight
Published: 2023-10-09 (Crawled : 21:00) - prnewswire.com
NVO | News | $126.16 -1.93% -2.24% 3M |

Health Technology

| 37.04% | O: 0.09% H: 1.41% C: 0.94%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -5.84% | O: 0.67% H: 0.56% C: -0.01%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -12.09% | O: 0.51% H: 0.0% C: 0.0%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -8.72% | O: 0.48% H: 1.39% C: 0.51%
ALPN | $64.57 0.03% 0.03% 1.2M |

Health Technology

| 451.17% | O: -1.07% H: 0.0% C: -6.9%
bleeding disease market

---

Graft Versus Host Disease Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Assesses DelveInsight | Key Companies - Glia, Incyte, Novartis, GlaxoSmithKline, Pfizer, BMS, Roche, AstraZeneca, Sanofi
Published: 2023-09-27 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -12.96% | O: -2.28% H: 0.0% C: -0.06%
MCRB | $0.7295 -4.01% -4.18% 5.7M |

Health Technology

| -69.46% | O: 0.42% H: 0.63% C: -0.42%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -12.06% | O: -1.61% H: 0.0% C: 0.0%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -12.47% | O: 0.03% H: 0.34% C: -0.88%
disease companies sanofi growth market

---

CAR T-cell Therapy for Multiple Myeloma Market to Observe Stunning Growth by 2032, Evaluates DelveInsight | Key Companies - Cartesian, Arcellx, Novartis, Bristol-Myers Squibb, CARsgen, Poseida, Juno, CRISPR, bluebird bio
Published: 2023-09-25 (Crawled : 21:00) - prnewswire.com
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -7.5% | O: -0.45% H: 0.0% C: 0.0%
MESO | $6.22 3.67% 3.38% 190K |

Health Technology

| -36.27% | O: -3.28% H: 5.93% C: 4.24%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -11.93% | O: -0.32% H: 1.81% C: 1.23%
companies t-cell therapy growth market

---

Intrahepatic Cholangiocarcinoma Market to Grow Rapidly During the Study Period (2019-2032), Examines DelveInsight | Key Players - Virogin Biotech, Syndax, Delcath Systems, AstraZeneca, Amgen, Jazz, BeiGene
Published: 2023-09-20 (Crawled : 21:00) - prnewswire.com
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 31.1% | O: -1.47% H: 0.0% C: 0.0%
XNCR | $19.02 3.54% 3.57% 760K |

Health Technology

| -7.45% | O: -0.39% H: 1.03% C: -0.59%
RLAY | $6.35 7.63% 6.94% 1.7M |

Health Technology

| -27.92% | O: -2.04% H: 0.87% C: -0.46%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -14.3% | O: -0.22% H: 0.25% C: -2.37%
BGNE | $144.12 3.69% 3.48% 190K |

Health Technology

| -25.26% | O: -2.14% H: 0.25% C: -0.49%
study market

---

Head and Neck Squamous Cell Carcinoma Market to Witness Upsurge in Growth by 2032, Assesses DelveInsight | Key Companies in the Market - Pfizer, Merck, Eisai, AstraZeneca, Innate, Roche, GlaxoSmithKline, BeiGene, IO Biotech, Incyte
Published: 2023-09-18 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -14.55% | O: -0.62% H: 0.0% C: -1.16%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 31.67% | O: 0.06% H: 1.19% C: 0.58%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -12.61% | O: -0.09% H: 1.16% C: 1.16%
MRUS | $41.97 2.82% 2.72% 740K |

Health Technology

| 68.69% | O: -0.16% H: 2.46% C: 0.56%
KURA | News | $18.75 0.11% 0.16% 820K |

Health Technology

| 95.52% | O: -0.1% H: 2.4% C: 0.52%
IOVA 4 | $11.71 -1.27% -1.45% 2.9M |

Health Technology

| 97.47% | O: -0.51% H: 1.5% C: -7.97%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -13.06% | O: 0.03% H: 2.18% C: 1.8%
FUSN | $21.4 -0.09% -0.09% 260K |

Health Technology

| 707.55% | O: 0.0% H: 0.41% C: -2.26%
CALT | $18.5 1.65% 1.62% 1K |

Health Technology

| 7.12% | O: -6.2% H: 4.2% C: 0.0%
BNTX | News | $88.09 -0.45% -0.35% 230K |

Health Technology

| -19.21% | O: -0.01% H: 1.99% C: 1.28%
companies cell growth market

---

Asthma Market is Predicted to Exhibit Remarkable Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - GlaxoSmithKline, AstraZeneca, Sanofi, Roche, Amgen, Regeneron, Incyte, Areteia, Suzhou Connect, Cumberland, Pulmatrix
Published: 2023-09-14 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -13.24% | O: 1.53% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -13.02% | O: 0.82% H: 0.0% C: 0.0%
RAPT | $7.9 -1.25% -1.2% 240K |

Health Technology

| -58.88% | O: 0.16% H: 1.61% C: 1.35%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -18.49% | O: -0.08% H: 0.76% C: -1.39%
companies growth market

---

Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen
Published: 2023-09-13 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -12.54% | O: 2.14% H: 0.0% C: -1.3%
INAB | $1.06 1.92% -0.97% 150K |

| 12.71% | O: 1.01% H: 3.23% C: -1.05%
BMEA | $10.77 -1.91% -2.04% 580K |

Professional, Scientific, and T...

| -27.25% | O: 0.24% H: 0.0% C: -2.96%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -12.51% | O: 0.26% H: 0.74% C: 0.33%
DTIL | $9.82 -4.01% -4.28% 31K |

Health Technology

| 2184.78% | O: -0.19% H: 4.62% C: -2.14%
KYMR | $35.21 -1.4% -1.51% 380K |

Health Technology

| 81.31% | O: 0.51% H: 1.74% C: -0.72%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -18.0% | O: 0.1% H: 1.09% C: 0.51%
CLLS | News | $2.5 -4.57% -3.55% 39K |

Health Technology

| 42.05% | O: 0.57% H: 0.56% C: -3.39%
BEAM | $22.74 -3.11% -3.21% 740K |

Health Technology

| -9.15% | O: 0.56% H: 1.15% C: -0.12%
companies leukemia market

---

Polycythemia Vera Market Grow Rapidly at a CAGR of 14% During the Study Period (2019-2032) | DelveInsight
Published: 2023-09-05 (Crawled : 21:00) - prnewswire.com
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 34.76% | O: 0.51% H: 0.1% C: -0.19%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -10.77% | O: -0.83% H: 0.19% C: -0.09%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -18.24% | O: -0.08% H: 0.44% C: -0.06%
study market

---

Essential Thrombocythemia Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies to Look Out - Imago BioSciences, Incyte, Karyopharm, Novartis, PharmaEssentia, Celgene, Kartos, Sierra Oncology
Published: 2023-08-30 (Crawled : 21:00) - prnewswire.com
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -20.7% | O: -0.09% H: 0.29% C: -1.01%
companies growth market

---

Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight
Published: 2023-08-21 (Crawled : 21:00) - prnewswire.com
COYA | News | $8.41 4.86% 3.14% 120K |

| 145.91% | O: 2.92% H: 4.26% C: -0.28%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 37.29% | O: 0.3% H: 1.19% C: 0.75%
URGN | $14.21 -2.2% -2.04% 97K |

Health Technology

| -30.14% | O: 0.0% H: 2.26% C: -0.34%
SEEL | $0.301 -7.98% -10.1% 600K |

Health Technology

| -99.18% | O: 0.0% H: 0.0% C: -9.02%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -11.7% | O: 0.57% H: 0.0% C: 0.0%
PRTA 4 | $20.56 0.15% 340K |

Health Technology

| -64.04% | O: 0.03% H: 1.36% C: -0.07%
IONS | $42.45 1.46% 1.45% 730K |

Health Technology

| 8.29% | O: -0.15% H: 1.02% C: 0.46%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -20.25% | O: -0.08% H: 1.11% C: -0.06%
DNLI | $15.56 -3.41% -3.6% 940K |

Health Technology

| -33.13% | O: -0.6% H: 1.75% C: 0.3%
BIVI | $0.5054 2.77% 2.13% 830K |

Health Technology

| -85.55% | O: -0.85% H: 3.43% C: 1.71%
BIIB | $201.99 4.56% 4.32% 2.7M |

Health Technology

| -23.8% | O: -0.38% H: 0.67% C: -0.41%
global medical growth market

---

Multiple Myeloma Market to Observe Impressive Growth at a CAGR of ~5% During the Study Period (2019-2032), Assesses DelveInsight
Published: 2023-08-14 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $94.0 -0.27% -2.18% 310 |

Health Technology

| -11.53% | O: -2.02% H: 0.0% C: -1.05%
JNJ | News | $148.53 -0.69% 0.18% 7.5M |

Health Technology

| -14.88% | O: -0.82% H: 0.0% C: 0.0%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -10.53% | O: 0.36% H: 0.0% C: 0.0%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -20.69% | O: -0.51% H: 1.22% C: 0.77%
CLLS | News | $2.5 -4.57% -3.55% 39K |

Health Technology

| 29.53% | O: 1.04% H: 3.08% C: 1.03%
growth study market

---

Bladder Cancer Market Likely to Exhibit Substantial Growth, Assesses DelveInsight | Leading Companies - CicloMed, Bristol-Myers Squibb, CG Oncology, Merck, Eli Lilly and Company, UroGen, Ferring
Published: 2023-08-07 (Crawled : 21:00) - prnewswire.com
ALPMY | News | $9.47 -0.21% -1.11% 400K |

Manufacturing

| -38.51% | O: 0.19% H: 0.0% C: -2.72%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 65.66% | O: 11.43% H: 6.32% C: 3.08%
URGN | $14.21 -2.2% -2.04% 97K |

Health Technology

| -28.95% | O: -1.3% H: 6.76% C: 5.57%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -18.69% | O: 2.58% H: 0.41% C: -1.13%
FUSN | $21.4 -0.09% -0.09% 260K |

Health Technology

| 608.61% | O: 10.6% H: 0.0% C: -9.58%
companies bladder cancer market

---

Merus Announces Financial Results for the Second Quarter 2023 and Provides Business Update
Published: 2023-08-07 (Crawled : 21:00) - globenewswire.com
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 65.66% | O: 11.43% H: 6.32% C: 3.08%
MRUS | $41.97 2.82% 2.72% 740K |

Health Technology

| 67.54% | O: 3.79% H: 1.72% C: -11.69%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -18.69% | O: 2.58% H: 0.41% C: -1.13%
business update financial results

---

Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim
Published: 2023-08-03 (Crawled : 21:00) - prnewswire.com
BMEA | $10.77 -1.91% -2.04% 580K |

Professional, Scientific, and T...

| -43.26% | O: -0.11% H: 4.35% C: 1.85%
LLY | News | $732.2 -1.81% -0.84% 1.7M |

Health Technology

| 66.62% | O: -0.53% H: 0.0% C: 0.0%
RCUS 4 | $15.43 -0.45% 0.0% 520K |

Health Technology

| -18.92% | O: 0.11% H: 1.42% C: -0.16%
SNY | News | $46.61 -2.27% -2.21% 1.6M |

Health Technology

| -5.43% | O: 2.43% H: 0.0% C: 0.0%
MRUS | $41.97 2.82% 2.72% 740K |

Health Technology

| 61.3% | O: -0.23% H: 1.85% C: 0.15%
INCY | $51.74 0.17% 0.14% 1.6M |

Health Technology

| -20.38% | O: -0.8% H: 0.99% C: -1.29%
GRTX | $0.1827 -5.83% -6.53% 810K |

Health Technology

| -91.93% | O: 0.45% H: 4.02% C: 0.45%
BNTX | News | $88.09 -0.45% -0.35% 230K |

Health Technology

| -17.4% | O: -0.01% H: 1.23% C: -0.15%
AGEN A | $7.42 14.86% 12.94% 1.2M |

Health Technology

| 411.72% | O: 0.69% H: 3.08% C: 0.0%
companies expected pancreatic tumor endocrine growth market

---

Gainers vs Losers

61%

39%

Top 10 Gainers

CSSE 4 | $0.4253 179.25% 64.77% 210M |

Consumer Services

BOF | $2.08 77.78% 41.21% 110M |

ILAG | $0.54 12.27% 40.62% 3.7M |

LICN | $0.999 78.39% 40.49% 15M |

AMST | $3.4 70.0% 39.58% 70M |

Technology Services

MTC | $3.6 60.71% 38.04% 9.1M |

Technology Services

WIMI | $1.15 58.53% 36.92% 19M |

Technology Services

AIH | $0.458 14.5% 30.92% 91K |

Health Services

WHLM | $6.25 35.87% 28.46% 700K |

Commercial Services

MULN | News | $3.77 38.1% 27.78% 13M |

Information

---

Your saved searches

---